HTG Molecular Diagnostics (HTGM)

HTG Molecular Diagnostics Financial Statements

HTG Molecular Diagnostics Financial Overview

HTG Molecular Diagnostics's market cap is currently ―. The company's EPS TTM is $-2.49; its P/E ratio is -0.43; HTG Molecular Diagnostics is scheduled to report earnings on August 9, 2022, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 1.18M$ 2.88M$ 2.52M$ 2.07M$ 1.44M
Gross Profit$ 329.41K$ 1.52M$ 1.54M$ 1.10M$ 649.95K
EBIT$ -6.25M$ -4.92M$ -4.22M$ -2.34M$ -4.58M
EBITDA$ -6.06M$ -4.77M$ -4.03M$ -2.16M$ -4.38M
Net Income Common Stockholders$ -6.50M$ -5.19M$ -4.49M$ -2.61M$ -4.85M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 21.56M$ 21.94M$ 25.42M$ 28.70M$ 29.76M
Total Assets$ 28.46M$ 30.46M$ 34.51M$ 37.32M$ 36.63M
Total Debt$ 6.78M$ 9.58M$ 10.75M$ 11.95M$ 12.34M
Net Debt$ -14.79M$ -12.37M$ -14.66M$ -16.75M$ -17.42M
Total Liabilities$ 17.20M$ 20.06M$ 19.62M$ 18.88M$ 19.79M
Stockholders Equity$ 10.40M$ 11.27M$ 14.48M$ 14.89M$ 16.20M
Cash Flow
Free Cash Flow$ -5.95M$ -3.44M$ -4.57M$ -4.69M$ -4.45M
Operating Cash Flow$ -5.94M$ -3.39M$ -4.22M$ -4.55M$ -4.35M
Investing Cash Flow$ 5.39M$ 2.80M$ 652.76K$ -7.33M$ -2.78M
Financing Cash Flow$ 5.57M$ -33.55K$ 222.20K$ 3.68M$ 6.53M
Currency in USD

HTG Molecular Diagnostics Earnings and Revenue History

HTG Molecular Diagnostics Debt to Assets

HTG Molecular Diagnostics Cash Flow

HTG Molecular Diagnostics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis